Matthew Furnas - Intermolecular Director
Director
Mr. Matthew S. Furnas is Independent Director of the Company. During his career, Mr. Furnas has developed expertise in analyzing and performing due diligence on companies in a wide array of industries through public and private equity investments. We believe Mr. Furnas qualifications to serve on our Board include his experience and expertise in accounting, financial analysis, and public company reporting. Mr. Furnas was a Senior Analyst at Raging Capital Management, LLC, a diversified investment firm, since 2010. He received a BS in Business Administration from Olin Business School at Washington University in St. Louis. Previously, on November 14, 2016, we entered into a governance agreement with Raging Capital. Under terms of the agreement, Raging Capital shall be allowed to nominate one additional director to our board for election at the 2017 Annual Meeting, subject to approval by the Nominating Committee, subject to its fiduciary duties, and be allowed to purchase no more than eight million additional shares as of the date of the agreement. Mr. Furnas was initially presented to the Nominating Committee as Raging Capitals designee pursuant to the governance agreement and is nominated for election at this Annual Meeting. since 2017.
| Age | 29 |
| Tenure | 7 years |
| Phone | 408 582-5700 |
| Web | www.intermolecular.com |
Intermolecular Management Efficiency
The company has Return on Asset of 12.76 % which means that on every $100 spent on assets, it made $12.76 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 35.45 %, implying that it generated $35.45 on every 100 dollars invested. Intermolecular's management efficiency ratios could be used to measure how well Intermolecular manages its routine affairs as well as how well it operates its assets and liabilities.The company has 13.65 M in debt with debt to equity (D/E) ratio of 49.1, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Intermolecular has a current ratio of 4.65, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Intermolecular until it has trouble settling it off, either with new capital or with free cash flow. So, Intermolecular's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intermolecular sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intermolecular to invest in growth at high rates of return. When we think about Intermolecular's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Charles Lathrop | Asure Software | 61 | |
| Brad Burrows | Asure Software | N/A | |
| Mary Winston | Plexus Corp | 52 | |
| Ralf Boer | Plexus Corp | 70 | |
| Thomas Waechter | NETGEAR | 64 | |
| Barbara Scherer | NETGEAR | 62 | |
| David Drury | Plexus Corp | 69 | |
| Daniel Gill | Asure Software | 53 | |
| Philip Martens | Plexus Corp | 54 | |
| Julie Shimer | NETGEAR | 65 | |
| Joycelyn CarterMiller | NETGEAR | 56 | |
| Randall Waterfield | Asure Software | 43 | |
| Christopher Genualdi | NETGEAR | N/A | |
| Bradley Maiorino | NETGEAR | 47 | |
| Janice Roberts | NETGEAR | 62 | |
| Joann Eisenhart | Plexus Corp | 58 | |
| Ralph Faison | NETGEAR | 58 | |
| Paul Rooke | Plexus Corp | 59 | |
| Grady Summers | NETGEAR | 39 | |
| Peter Kelly | Plexus Corp | 61 | |
| Jef Graham | NETGEAR | 60 | |
Management Performance
| Return On Equity | 35.45 | |||
| Return On Asset | 12.76 |
Intermolecular Leadership Team
Elected by the shareholders, the Intermolecular's board of directors comprises two types of representatives: Intermolecular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intermolecular. The board's role is to monitor Intermolecular's management team and ensure that shareholders' interests are well served. Intermolecular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intermolecular's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christian Kramer, President CEO | ||
| Thomas Baruch, Independent Director | ||
| Kenneth Traub, Independent Director | ||
| Jonathan Schultz, Director | ||
| C Neely, CFO, Principal Financial and Accounting Officer | ||
| Bruce McWilliams, Chairman, CEO and Pres | ||
| Matthew Furnas, Director | ||
| Bill Roeschlein, CFO, Principal Financial & Principal Accounting Officer | ||
| Irwin Federman, Independent Director | ||
| Adam Scheer, Director | ||
| George Scalise, Independent Director | ||
| Scot Griffin, Sr. VP of Bus. Operations and Corporate Secretary | ||
| Marvin Burkett, Independent Director |
Intermolecular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intermolecular a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 35.45 | |||
| Return On Asset | 12.76 | |||
| Profit Margin | 12.89 % | |||
| Operating Margin | (45.02) % | |||
| Current Valuation | 49.2 M | |||
| Shares Outstanding | 49.76 M | |||
| Shares Owned By Insiders | 30.13 % | |||
| Shares Owned By Institutions | 0.37 % | |||
| Number Of Shares Shorted | 4.43 K | |||
| Price To Earning | (3.08) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Intermolecular Stock
If you are still planning to invest in Intermolecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intermolecular's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |